Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 98

Sort by

Sort Order Select

Journal Articles

BTN2A, a New Immune-Checkpoint Targeting Vg9Vd2 T Cell Cytotoxicity

Carla E Cano, PhD, Christine Pasero, Aude De Gassart, René Hoet, Emmanuel Scotet, Erwan Mortier, Agnes Quemeneur, Chirine Rafia, Antoine Briantais, Anne-Charlotte Le Floch, MBBS,MSc, Daniel Olive, MD PhD

Blood (2019) 134 (Supplement_1): 1044.

https://doi.org/10.1182/blood-2019-128658

Published: 2019

Journal Articles

Allogeneic Chimeric Antigen Receptor-Invariant Natural Killer T Cells Exert Both Direct and Indirect Antitumor Effects through Host CD8 T Cell Cross-Priming

Federico Simonetta, MD PhD, Toshihito Hirai, MD PhD, Juliane K. Lohmeyer, MD, Kristina Maas-Bauer, MD, Maite Alvarez, PhD, Arielle S. Wenokur, Jeanette Baker, Amin Aalipour, PhD, Samuel Haile, PhD, Crystal L. Mackall, MD, Robert S. Negrin, MD

Blood (2019) 134 (Supplement_1): 867.

https://doi.org/10.1182/blood-2019-122515

Published: 2019

Journal Articles

Development of an Immunotherapeutic Monoclonal Antibody Recognizing DKK1-HLA-A2 Complex to Treat Human Hematologic Malignancies

Jianfei Qian, PhD, Qiang Wang, PhD, Lintao Liu, PhD, Enguang Bi, PhD, Xingzhe Ma, PhD, Pan Su, PhD, Maojie Yang, Qing Yi, MD PhD

Blood (2019) 134 (Supplement_1): 5551.

https://doi.org/10.1182/blood-2019-123541

Published: 2019

Journal Articles

Suppression of FVIII Antibody Production By FVIII BAR T-Cell in Vitro in the Presence of Inhibitors

Kalpana Parvathaneni, PhD, Ai-Hong Zhang, PhD, David W. Scott, PhD

Blood (2018) 132 (Supplement 1): 3789.

https://doi.org/10.1182/blood-2018-99-115278

Published: 2018

Journal Articles

Factor VIII BAR T-Cell Recognition By Antibodies to Different Domains

Kalpana Parvathaneni, PhD, Katherine Pohida, B.S., David W. Scott, PhD

Blood (2018) 132 (Supplement 1): 1171.

https://doi.org/10.1182/blood-2018-99-113375

Published: 2018

Journal Articles

Novel Antibodies Against Glycoprotein Ibα Inhibit Pulmonary Metastasis By Affecting Vwf-Gpibα Interaction

Qi Yingxue, Wenchun Chen, PhD, Ke Xu, Fengying Wu, Xuemei Fan, Shengxiang Ren, Junling Liu, Wei Deng, PhD, Jun Zhang, Renhao Li, PhD, Jianwen Liu, Xin Liang, PhD

Blood (2018) 132 (Supplement 1): 1133.

https://doi.org/10.1182/blood-2018-99-117613

Published: 2018

Journal Articles

Primary Chronic Lymphocytic Leukemia Cells Can be Maintained Long-Term in Serum-Free, Cytokine-Free 3D Culture

Joana Dos Santos, MSc, Louise Enfield, Susana Brito Dos Santos, MSc, Mark C Allenby, MSc, Sophie Zemenides, MD, Athanasios Mantalaris, PhD, Nicki Panoskaltsis, MD PhD FRCP

Blood (2017) 130 (Supplement 1): 2989.

https://doi.org/10.1182/blood.V130.Suppl_1.2989.2989

Published: 2017

Journal Articles

Incorporation of 4-1BB Endowed the Potent CD33 Specific Chimeric Antigen Receptor T Cells with Anti-Exhaustion Capacity and Increased Central Memory Compartment

Saisai Li, PhD, Zhongfei Tao, PhD, Yingxi Xu, PhD, Jia Liu, Na An, Ying Wang, PhD, Zheng Tian, Haiyang Xing, Kejing Tang, Xiaolong Liao, Qing Rao, MS, Min Wang, MD, Jianxiang Wang, MD

Blood (2017) 130 (Supplement 1): 2636.

https://doi.org/10.1182/blood.V130.Suppl_1.2636.2636

Published: 2017

Journal Articles

Next Generation Sequencing of Immunized Mouse Splenocytes to Develop an Anti-TIM3 Chimeric Antigen Receptor for Acute Myeloid Leukemia

Justin C. Boucher, PhD, Paresh Vishwasrao, Lawrence Guan, Bishwas Shrestha, PhD, Gongbo Li, PhD MBBS, Scott Christley, Lindsay G. Cowell, PhD, Jared Ostmeyer, William H. Rounds, Inimary T. Toby, PhD, Marco L. Davila, MD PhD

Blood (2017) 130 (Supplement 1): 2646.

https://doi.org/10.1182/blood.V130.Suppl_1.2646.2646

Published: 2017

Journal Articles

B-Cell Receptor Antigens As the Targeting Moiety for Bispecific Constructs - a Novel Treatment Approach for B-Cell Lymphomas

Moritz Bewarder, MD, Lorenz Thurner, MD, Klaus Dieter Preuss, PhD, Evi Regitz, Natalie Fadle, Michael Pfreundschuh, MD

Blood (2017) 130 (Supplement 1): 111.

https://doi.org/10.1182/blood.V130.Suppl_1.111.111

Published: 2017

Journal Articles

A Novel Monoclonal Antibody Against A2 Domain of Von Willebrand Factor Reduces Its Proteolysis By ADAMTS13

Lulu Zhang, Jian Su, Fei Shen, Zhenni MA, Yiming Zhao, Ziqiang Yu, Changgeng Ruan

Blood (2016) 128 (22): 2575.

https://doi.org/10.1182/blood.V128.22.2575.2575

Published: 2016

Journal Articles

FLT3 Splice Variant (FLT3Va) As a Potential Immunotherapeutic Target in Patients with Acute Myeloid Leukemia (AML)

Sophia Adamia, PhD, Jeffrey Nemeth, PhD, Shruti Bhatt, PhD, Sarah R Walker, Natalie I Voeks, William Lento, PhD, Ricardo M. Attar, Ilene Galinsky, MSN, ANPc, David A Frank, MD PhD, Martha Wadleigh, MD, Anthony Letai, MD PhD, David P. Steensma, MD, David M. Weinstock, MD, Daniel J. DeAngelo, MD PhD, David M. Dorfman, MD PhD, Richard M. Stone, MD, James D Griffin, MD

Blood (2016) 128 (22): 1681.

https://doi.org/10.1182/blood.V128.22.1681.1681

Published: 2016

Journal Articles

A Novel Dual Monoclonal Sandwich ELISA for Human Erythroferrone

Huiling Han, MD, Keith Westerman, BS, Vaughn Ostland, PhD, Patrick Gutschow, MS, Gordana Olbina, PhD, Jacqueline da Silva Guimarães, PhD, Juçara Gastaldi Cominal, M.Sc, Ana Maria de Souza, PhD, Ana Cristina Silva Pinto, MD, Stefano Rivella, PhD, Yelena Ginzburg, MD, Mark D. Fleming, MD DPhil, Mark Westerman, PhD

Blood (2016) 128 (22): 1272.

https://doi.org/10.1182/blood.V128.22.1272.1272

Published: 2016

Journal Articles

CD3/Bars: A Novel Bispecific Format for the Treatment of B-Cell Lymphomas

Moritz Bewarder, MD, Klaus-Dieter Preuss, PhD, Natalie Fadle, Evi Regitz, Lorenz Thurner, MD, Michael Pfreundschuh, MD, PhD

Blood (2016) 128 (22): 3516.

https://doi.org/10.1182/blood.V128.22.3516.3516

Published: 2016

Journal Articles

Novel Humanised ROR1 Chimeric Antigen Receptors for the Treatment of Haematological Malignancies

Satyen Harish Gohil, MBBS MRCP FRCPath, Marco Della Peruta, PhD, Solange R Paredes-Moscosso, Micaela Harrasser, Gordon Weng-Kit Cheung, MSc, David M Davies, PhD, Martin A Pule, MD PhD, Amit C Nathwani, MD PhD

Blood (2016) 128 (22): 3361.

https://doi.org/10.1182/blood.V128.22.3361.3361

Published: 2016

Journal Articles

Treatment of Patients with Steroid Refractory Acute Graft Vs Host Disease (SR-GvHD): A Matched Paired Analysis of Anti-CD26 (Begelomab) Compared to Other Treatment

Andrea Bacigalupo, MD, H. Joachim Deeg, MD, Dolores Caballero, MD PhD, Francesca Gualandi, MD, Anna Maria Raiola, MD, Riccardo Varaldo, MD, Carmen Di Grazia, MD, Lucia López Corral, PhD MD, Maria Teresa van Lint, MD

Blood (2016) 128 (22): 671.

https://doi.org/10.1182/blood.V128.22.671.671

Published: 2016

Journal Articles

Targeted Inhibition of Activated Protein C Anticoagulant Activity By Monoclonal Antibody HAPC1573 for Treatment of Hemophilia

Xiao-Yan Zhao, PhD, Subramanian Yegneswaran, PhD, Maxine Bauzon, Derek Sim, Chandra Patel, PhD, Doug Schneider, Kirk McLean, Ying Zhu, MD, Xiaoqiao Jiang, Vince Evans, Jian-Ming Gu, PhD, Inge Ivens, PhD, Jun Xu, PhD, Peter Wolfgang Bringmann, PhD, Katalin Kauser, Charles Esmon, PhD

Blood (2016) 128 (22): 80.

https://doi.org/10.1182/blood.V128.22.80.80

Published: 2016

Journal Articles

Novel ROR1 Antibody Is Able to Trigger Specific and Superior Complement-Dependent Cytotoxicity (CDC) on Primary CLL Cells

Solange R Paredes-Moscosso, Marco Della Peruta, PhD, Satyen Harish Gohil, MBBS MRCP FRCPath, Micaela Harrasser, Amit C Nathwani, MD PhD

Blood (2016) 128 (22): 2052.

https://doi.org/10.1182/blood.V128.22.2052.2052

Published: 2016

Journal Articles

The Trifunctional Antibody (tri-31C2) Targeting CD38 and CD3 Has a Stronger Anti-Myeloma Effect Than the Chimeric Anti-CD38 Monoclonal Antibody (ch-31C2)

Tadao Ishida, MD PhD, Hiroshi Yasui, MD PhD, Kazuya Ishiguro, MD, Yuka Aoki, MD PhD, Hiroshi Ikeda, MD PhD

Blood (2016) 128 (22): 2097.

https://doi.org/10.1182/blood.V128.22.2097.2097

Published: 2016

Journal Articles

Quantitative Baseline Circulating Tumor DNA Levels Correlate with GM-CSF Response to Idiotype Vaccine in Untreated Mantle Cell Lymphoma

Mark Roschewski, MD, Kieron Dunleavy, MD, Sattva S. Neelapu, MD, Stefania Pittaluga, MD PhD, Christopher Joseph Melani, MD, Elaine S. Jaffe, MD, Margaret Shovlin, RN, Beryl Crossley, BS, Katie Kong, BS, Allison Jacob, MD, Larry Kwak, Wyndham H. Wilson, MD PhD

Blood (2016) 128 (22): 2943.

https://doi.org/10.1182/blood.V128.22.2943.2943

Published: 2016

NARROW

BTN2A, a New Immune-Checkpoint Targeting Vg9Vd2 T Cell Cytotoxicity

Allogeneic Chimeric Antigen Receptor-Invariant Natural Killer T Cells Exert Both Direct and Indirect Antitumor Effects through Host CD8 T Cell Cross-Priming

Development of an Immunotherapeutic Monoclonal Antibody Recognizing DKK1-HLA-A2 Complex to Treat Human Hematologic Malignancies

Suppression of FVIII Antibody Production By FVIII BAR T-Cell in Vitro in the Presence of Inhibitors

Factor VIII BAR T-Cell Recognition By Antibodies to Different Domains

Novel Antibodies Against Glycoprotein Ibα Inhibit Pulmonary Metastasis By Affecting Vwf-Gpibα Interaction

Primary Chronic Lymphocytic Leukemia Cells Can be Maintained Long-Term in Serum-Free, Cytokine-Free 3D Culture

Incorporation of 4-1BB Endowed the Potent CD33 Specific Chimeric Antigen Receptor T Cells with Anti-Exhaustion Capacity and Increased Central Memory Compartment

Next Generation Sequencing of Immunized Mouse Splenocytes to Develop an Anti-TIM3 Chimeric Antigen Receptor for Acute Myeloid Leukemia

B-Cell Receptor Antigens As the Targeting Moiety for Bispecific Constructs - a Novel Treatment Approach for B-Cell Lymphomas

A Novel Monoclonal Antibody Against A2 Domain of Von Willebrand Factor Reduces Its Proteolysis By ADAMTS13

FLT3 Splice Variant (FLT3Va) As a Potential Immunotherapeutic Target in Patients with Acute Myeloid Leukemia (AML)

A Novel Dual Monoclonal Sandwich ELISA for Human Erythroferrone

CD3/Bars: A Novel Bispecific Format for the Treatment of B-Cell Lymphomas

Novel Humanised ROR1 Chimeric Antigen Receptors for the Treatment of Haematological Malignancies

Treatment of Patients with Steroid Refractory Acute Graft Vs Host Disease (SR-GvHD): A Matched Paired Analysis of Anti-CD26 (Begelomab) Compared to Other Treatment

Targeted Inhibition of Activated Protein C Anticoagulant Activity By Monoclonal Antibody HAPC1573 for Treatment of Hemophilia

Novel ROR1 Antibody Is Able to Trigger Specific and Superior Complement-Dependent Cytotoxicity (CDC) on Primary CLL Cells

The Trifunctional Antibody (tri-31C2) Targeting CD38 and CD3 Has a Stronger Anti-Myeloma Effect Than the Chimeric Anti-CD38 Monoclonal Antibody (ch-31C2)

Quantitative Baseline Circulating Tumor DNA Levels Correlate with GM-CSF Response to Idiotype Vaccine in Untreated Mantle Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only